Biocybernetics

Exclusive: Interview with US presidential candidate

Zoltan Istvan to challenge Trump in 2020; solving Longevity is at the top of his agenda. Last week, the transhumanist activist Zoltan Istvan announced his...

Meet Peter 2.0: One step closer to the Singularity

When Dr Peter Scott-Morgan was diagnosed with motor neurone disease, he decided to challenge what it means to be human. “Peter 2.0 is now online.”...

Closed-loop pancreas system aces trial

Tandem and Dexcom system aces closed-loop pancreas trial for type 1 diabetes, but doesn't appear to break new ground over existing market competitor. A clinical...

Closed-loop artificial pancreas slated to drastically improve lifespan

Cambridge University team release patient test results of insulin pump for artificial pancreas and monitoring device powered by AI. Of all of the adjectives that...

Totally artificial heart implant extends life in research breakthrough

Risks of leaving a diseased heart in situ are eliminated after US university team's artificial heart breakthrough. An artificial device implanted in the chest of...

‘Blood scrubbing’ device could improve lifespan

Scientists develop 'blood scrubbing' device capable of filtering out tumorous cells from the bloodstream. Tumours become deadly when they metastasise, sending cancerous cells through the...

New grant brings artificial lung – and Longevity – one step closer

New funding is propelling one US university along the fast track to artificial lungs – this could mean the difference between life and death...

Latest articles

VC enters Longevity market with K4Connect deal

We talk with VC investor Forte Ventures about its first foray into AgeTech, COVID-19 and the Longevity investment opportunity. Longevity agetech company K4Connect has announced...

Challenging the one drug/one disease model

A new paper supports the targeting of aging processes, rather than just one disease, to improve Longevity outcomes. Multimorbidity is a challenge for Longevity; defined...

Robotics and AI combine for new therapeutics discovery

Insilico Medicine and Arctoris announce robotics/AI partnership to focus on COVID-19 inhibitors that could have wide-reaching benefits for Longevity. Two companies have joined forces in...

The results are in: sharing our Longevity investment survey

There is rapidly-increasing activity in both the research and the investment communities that focus on Longevity; this survey gets into the details. The global Longevity...